It's worth clarifying that the adenovirus-based (viral vector) vaccines that article is discussing were a completely different technology from the mRNA vaccines.
The mRNA vaccines also had a cloth problem (as in, it was extremely rare), that practically disappeared with a change on the application procedure.
The mRNA vaccines also had a cloth problem (as in, it was extremely rare), that practically disappeared with a change on the application procedure.